| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $238.7M | +2.0% | +3.2% |
| Cost of Revenue | $25.2M | +60.5% | +0.3% |
| Gross Profit | $213.5M | +4.5% | +17.0% |
| R&D Expense | $36.3M | +5.7% | -0.1% |
| SG&A Expense | $28.5M | +5.2% | +1.0% |
| Operating Income | $54.7M | +120.1% | +99.3% |
| Pre-tax Income | $56.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $178.8M | -22.7% | -27.5% |
| Accounts Receivable | $39.6M | -3.5% | -11.1% |
| Inventory | $0 | -100.0% | -100.0% |
| Current Assets | $269.4M | -12.8% | -17.5% |
| Total Assets | $660.5M | -9.0% | -15.1% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $212.2M | — | — |
| Capital Expenditures | $5.2M | — | — |
| Investing Cash Flow | -$22.6M | — | — |
| Financing Cash Flow | -$319.0M | — | — |
| Free Cash Flow | $207.0M | — | — |
| +106.4% |
| +88.2% |
| Income Tax | $11.8M | +134.0% | +57.0% |
| Net Income | $44.7M | +100.1% | +98.6% |
| EPS (Basic) | $0.46 | +100.0% | +109.1% |
| EPS (Diluted) | $0.45 | +104.5% | +114.3% |
| $93.9M |
| -3.4% |
| -15.1% |
| Long-term Debt | $0 | — | — |
| Total Liabilities | $285.0M | -1.9% | -3.3% |
| Stockholders' Equity | $375.4M | -13.8% | -22.3% |